Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00838721 · ClinicalTrials.gov registry record · NA
Evaluation of Pascal Laser Trabeculoplaty
A NA study, sponsored by Santa Clara Valley Health & Hospital System.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00838721: Completed NA study, sponsored by Santa Clara Valley Health & Hospital System.
NCT00838721 is a NA study that has completed, run by Santa Clara Valley Health & Hospital System. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00838721, a NA study, has completed, sponsored by Santa Clara Valley Health & Hospital System.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Laser Trabeculoplasty has been shown to be effective in lowering intraocular pressure (IOP) in patients with primary open-angle glaucoma (POAG). Although initially demonstrated with the Argon laser (ALT), several other laser systems have also been employed with comparable efficacy. Recently, Selective Laser Trabeculoplasty (SLT) has been shown to lower intraocular pressure comparable to ALT. The advantage of SLT is that the target eye structure, the trabecular meshwork, remains intact with minimal damage at the cellular level. In contrast, ALT lowers IOP at the expense of scarring of the trabecular meshwork. The purpose of this study is to evaluate the efficacy of lowering IOP with Pascal Laser Trabeculoplasty (PLT) employing reduced energy levels compared to ALT and a computer guided pattern of laser treatment applications.
Interventions
- OTHER laser trabeculoplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-03 |
| Phase | NA |
What the finished NCT00838721 record still lists
NCT00838721 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which laser trabeculoplasty is the first listed.
NCT00838721 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00838721 about?
NCT00838721 is a clinical study titled "Evaluation of Pascal Laser Trabeculoplaty". Laser Trabeculoplasty has been shown to be effective in lowering intraocular pressure (IOP) in patients with primary open-angle glaucoma (POAG). Although initially demonstrated with the Argon laser (ALT), several other laser systems have also been employed with comparable efficacy. Recently, Selecti...
What is the current status of trial NCT00838721?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2008-03. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00838721?
The interventions under investigation include: laser trabeculoplasty (OTHER).
Who is sponsoring clinical trial NCT00838721?
This trial is sponsored by Santa Clara Valley Health & Hospital System, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00838721's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia